Korean professional skincare is gaining serious attention in Australian clinics, and not simply because it is new. Practitioners are being drawn to treatment systems that combine strong efficacy with intelligent formulation, lower-irritation approaches and the versatility to work across multiple professional modalities.
RIBESKIN Deep Shoot LUMI is a good example. Since launching in Australia, it has become a favourite for clinics treating pigmentation, uneven tone and dullness, particularly because it can be incorporated into microneedling, nanoneedling, laser, spicule treatments and broader combination programs.
Now, RIBESKIN has released new human clinical results for Deep Shoot LUMI, adding another layer of evidence behind a product Australian clinics were already reaching for.
What is Deep Shoot LUMI?
Deep Shoot LUMI is RIBESKIN’s Korean-made professional brightening serum, developed for pigmentation, uneven tone and skin luminosity.
At the heart of the formula is tranexamic acid, supported by niacinamide, glutathione and an amino acid complex. Rather than relying on one brightening ingredient, LUMI brings together several actives that allow practitioners to take a more considered approach to the appearance of pigmentation and uneven skin tone.
That makes sense in the treatment room because pigmentation rarely presents as an isolated concern. The same client may also be experiencing dullness, post-inflammatory discolouration, uneven texture or a general loss of luminosity.
LUMI gives the practitioner one clearly targeted professional formula that can be worked into a much wider treatment strategy.
The new clinical results
The latest human clinical evaluation was conducted by COREDERM Skin Research Center and assessed Deep Shoot LUMI on hyperpigmented areas over four weeks.
The study reported an average 11.51% improvement in skin clarity in hyperpigmented areas after four weeks of use.
The participant feedback was also impressive, with 95% reporting that their pigmentation areas appeared clearer and 95% reporting overall satisfaction with the product. The study also recorded a skin irritation score of 0.00 in its primary human skin irritation assessment.
For professional clinics, that is meaningful because it gives us measurable product-specific evidence alongside the ingredient science practitioners already understand.
It also reflects a shift we are seeing across the professional industry. Clinics increasingly want more than an impressive ingredient list. They want to know why a product belongs in the treatment room and what evidence sits behind it.
Why Australian clinics have taken to LUMI so quickly
One of the biggest strengths of LUMI is that it does not need to belong to one signature facial.
It can become the clinic’s go-to professional brightening serum whenever pigmentation, clarity or luminosity is part of the treatment objective.
A practitioner may incorporate it into a brightening nano-infusion facial, use it within a microneedling program, or build it into a longer-term pigmentation strategy alongside laser, spicules or other advanced modalities.
That flexibility is particularly valuable for clinics that are moving away from long menus of disconnected facials and towards treatment programs built around the client’s skin.
Instead of asking which facial the product belongs to, the practitioner can ask a much more useful question: what are we trying to achieve with this treatment?
When the answer is brighter, clearer and more even-looking skin, LUMI has a very obvious place.
Why tranexamic acid has become so important in pigmentation treatment
Much of the professional interest in LUMI centres around tranexamic acid, which has become an increasingly important ingredient in modern pigmentation treatment, particularly when working with melasma and uneven pigmentation.
Unlike an exfoliating ingredient that simply focuses on removing cells from the surface, tranexamic acid is interesting because of its relationship with pathways involved in pigment formation.
This has also made it particularly relevant to combination treatment programs, where clinics are no longer relying on one product or one piece of technology to address a complex concern such as pigmentation.
A practitioner may be working on visible pigment with a professional modality while simultaneously thinking about the biochemical processes that contribute to recurring uneven tone. That broader approach is one of the reasons tranexamic acid has become so prominent in advanced clinics.
LUMI + microneedling
Microneedling remains one of the most widely used corrective treatments in Australian skin clinics, and it is easy to understand why LUMI has become such a natural fit.
When pigmentation, uneven tone or dullness is the treatment priority, practitioners can pair their needling treatment with a professional serum specifically selected around that goal rather than defaulting to a general-purpose ampoule.
There is also growing research around the combination of microneedling and topical tranexamic acid in pigmentation and melasma treatment, which has increased professional interest in this category considerably.
This is where products such as LUMI become particularly valuable. The practitioner has a familiar modality in microneedling, but the serum allows them to give the treatment a much more targeted brightening direction.
LUMI + nanoneedling
Nanoneedling and nano-infusion treatments have opened another opportunity for clinics wanting to create sophisticated brightening treatments at a different level of intensity.
For a client focused on luminosity, clarity and an even-looking complexion, LUMI can become the centrepiece of a beautiful nano treatment while still sitting within the same broader pigmentation philosophy as the clinic’s more advanced services.
This also makes it easier to create a treatment journey rather than a single isolated appointment. A client’s program may move between nano treatments, microneedling and other professional modalities according to their goals and treatment plan, while LUMI provides a consistent brightening thread throughout.
LUMI + professional spicule treatments
One of the most interesting developments in professional Korean skincare has been the rise of spicule-based treatments, and this creates another exciting opportunity for LUMI within combination treatment programs.
RIBESKIN’s own G-PEEL DUAL is a good example.
G-PEEL DUAL combines high-purity hydrolysed sponge spicules with a dual delivery concept. Its Dual Layer Silica incorporates PDRN and retinol, while its accompanying Dual Synergy B3 formula contains 5% niacinamide, a stabilised vitamin C derivative, glutathione, vitamin E, ceramide and hyaluronic acid. RIBESKIN positions the treatment around both regeneration and brightening.
That makes the relationship between G-PEEL DUAL and LUMI particularly interesting for clinics specialising in pigmentation.
Rather than thinking of spicules as simply another form of exfoliation, practitioners can build more sophisticated brightening programs in which different treatments have different roles. A treatment such as G-PEEL DUAL can provide the resurfacing, renewal and spicule component of the program, while Deep Shoot LUMI provides a targeted professional brightening formula centred around tranexamic acid.
RIBESKIN’s own professional education positions G-PEEL DUAL within brightening and pigmentation programs, including combination programs with pigment care, IPL and toning laser.
For clinics already offering Korean spicule treatments, this creates an opportunity to think beyond the individual treatment and design a complete pigmentation journey.
LUMI + laser and advanced pigmentation treatments
The same philosophy applies in clinics working with laser and other advanced technology.
Modern pigmentation treatment is increasingly becoming a combination-treatment conversation rather than a search for one perfect modality.
A clinic may use laser technology to target visible pigmentation while professional skincare forms another part of the strategy for improving the appearance of skin tone and clarity over time. Tranexamic acid has attracted significant attention within this area, including research into its use alongside laser-based treatments for melasma and pigmentation.
Deep Shoot LUMI therefore fits particularly well into clinics that already think in terms of treatment programs rather than individual appointments.
The laser does not need to do the same job as the serum, just as the serum does not need to do the same job as microneedling or a spicule treatment. The strength comes from the practitioner understanding what each element contributes and bringing those elements together intelligently.
There is more to the formula than tranexamic acid
Although tranexamic acid tends to receive the most attention, the rest of the LUMI formulation is equally relevant.
Niacinamide has an established place in professional pigmentation care and is particularly interesting because of its effect on melanosome transfer within the epidermis. It also brings the additional benefit of supporting the skin barrier, making it an incredibly useful ingredient when treating clients whose concerns extend beyond pigment alone.
Glutathione adds antioxidant and brightening support, while the amino acid complex contributes to the wider condition and hydration of the skin.
It is the combination that makes LUMI so useful. Rather than building the entire product around one fashionable ingredient, RIBESKIN has created a formula that can sit comfortably within the kind of multi-dimensional treatments advanced clinics are already performing.
The bigger reason LUMI has become a clinic favourite
For us, this is ultimately what makes Deep Shoot LUMI such a strong treatment-room product.
It gives the practitioner options.
The same brightening formula can sit within a luminous nano facial, a targeted microneedling treatment, a professional spicule program with treatments such as G-PEEL DUAL, or a more advanced pigmentation journey incorporating laser and other technologies.
That versatility means LUMI does not need to disappear from the treatment menu once the excitement of a launch is over. It becomes part of how the clinic treats pigmentation.
The new clinical data now gives practitioners another reason to feel confident in that choice, with the four-week evaluation reporting an 11.51% improvement in skin clarity in hyperpigmented areas, alongside 95% participant-reported improvement in the appearance of pigmentation and 95% overall satisfaction.
For Australian clinics focused on pigmentation, luminosity and more even-looking skin, Deep Shoot LUMI is proving valuable not because it belongs to one treatment, but because it can become the brightening serum practitioners reach for across many of them.
And as professional skincare continues to move towards more intelligent combination treatment, that versatility is becoming increasingly important.
Leave a comment